Colour theme
Theme
Sign in
Insider · CIK 0001886431

Fitzgerald Kevin Joseph

CIK 0001886431 Name as filed on the most recent filing

Filed as Fitzgerald Kevin Joseph (13)

152 transaction lines · from 13 filings · filed 2024-06-26 to 2026-03-06 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

152 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2025-02-28 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 187 disposed 242.44 45,336.28 Form 4, filing 0001735276-25-000019
2025-02-28 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 79 disposed 241.51 19,079.29 Form 4, filing 0001735276-25-000019
2025-02-28 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 75 disposed 243.23 18,242.25 Form 4, filing 0001735276-25-000019
2025-02-28 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 48 disposed 240.32 11,535.36 Form 4, filing 0001735276-25-000019
2025-02-28 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 37 disposed 244.11 9,032.07 Form 4, filing 0001735276-25-000019
2025-02-28 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 27 disposed 236.51 6,385.77 Form 4, filing 0001735276-25-000019
2025-02-28 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 22 disposed 239.18 5,261.96 Form 4, filing 0001735276-25-000019
2025-02-28 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 21 disposed 238.33 5,004.93 Form 4, filing 0001735276-25-000019
2025-02-18 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 1,086 disposed 250.21 271,728.06 Form 4, filing 0001735276-25-000010
2025-02-18 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 115 disposed 251.60 28,934.00 Form 4, filing 0001735276-25-000010
2025-02-18 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 83 disposed 259.10 21,505.30 Form 4, filing 0001735276-25-000010
2025-02-18 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 80 disposed 256.05 20,484.00 Form 4, filing 0001735276-25-000010
2025-02-18 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 76 disposed 257.79 19,592.04 Form 4, filing 0001735276-25-000010
2025-02-14 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 164 disposed 253.37 41,552.68 Form 4, filing 0001735276-25-000010
2025-02-14 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 145 disposed 252.50 36,612.50 Form 4, filing 0001735276-25-000010
2025-02-14 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 110 disposed 254.35 27,978.50 Form 4, filing 0001735276-25-000010
2025-02-14 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 53 disposed 256.29 13,583.37 Form 4, filing 0001735276-25-000010
2025-02-14 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 47 disposed 255.56 12,011.32 Form 4, filing 0001735276-25-000010
2025-02-14 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 33 disposed 258.07 8,516.31 Form 4, filing 0001735276-25-000010
2025-02-14 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 26 disposed 261.45 6,797.70 Form 4, filing 0001735276-25-000010
2025-02-14 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 26 disposed 257.51 6,695.26 Form 4, filing 0001735276-25-000010
2025-02-14 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 21 disposed 260.57 5,471.97 Form 4, filing 0001735276-25-000010
2025-02-14 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 14 disposed 264.87 3,708.18 Form 4, filing 0001735276-25-000010
2025-02-14 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 12 disposed 263.33 3,159.96 Form 4, filing 0001735276-25-000010
2025-02-14 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 12 disposed 259.72 3,116.64 Form 4, filing 0001735276-25-000010
2024-11-27 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 851 disposed 251.98 214,434.98 Form 4, filing 0001735276-24-000104
2024-11-27 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 360 disposed 253.44 91,238.40 Form 4, filing 0001735276-24-000104
2024-11-27 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 210 disposed 250.45 52,594.50 Form 4, filing 0001735276-24-000104
2024-11-27 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 110 disposed 254.48 27,992.80 Form 4, filing 0001735276-24-000104
2024-11-26 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 826 disposed 251.42 207,672.92 Form 4, filing 0001735276-24-000104
2024-11-26 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 318 disposed 250.68 79,716.24 Form 4, filing 0001735276-24-000104
2024-11-26 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 215 disposed 249.60 53,664.00 Form 4, filing 0001735276-24-000104
2024-11-26 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 84 disposed 252.27 21,190.68 Form 4, filing 0001735276-24-000104
2024-11-26 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 26 disposed 247.77 6,442.02 Form 4, filing 0001735276-24-000104
2024-08-12 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 9,662 disposed 270.17 2,610,382.54 Form 4, filing 0001735276-24-000083
2024-08-12 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 5,736 disposed 271.32 1,556,291.52 Form 4, filing 0001735276-24-000083
2024-08-12 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 3,913 disposed 272.43 1,066,018.59 Form 4, filing 0001735276-24-000083
2024-08-12 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 1,421 disposed 268.66 381,765.86 Form 4, filing 0001735276-24-000083
2024-08-12 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 1,158 disposed 273.73 316,979.34 Form 4, filing 0001735276-24-000083
2024-08-12 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 135 disposed 274.65 37,077.75 Form 4, filing 0001735276-24-000083
2024-06-25 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 227 disposed 229.93 52,194.11 Form 4, filing 0001735276-24-000065
2024-06-25 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 198 disposed 229.06 45,353.88 Form 4, filing 0001735276-24-000065
2024-06-25 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 161 disposed 232.54 37,438.94 Form 4, filing 0001735276-24-000065
2024-06-25 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 138 disposed 234.66 32,383.08 Form 4, filing 0001735276-24-000065
2024-06-25 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 125 disposed 235.19 29,398.75 Form 4, filing 0001735276-24-000065
2024-06-25 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 96 disposed 228.30 21,916.80 Form 4, filing 0001735276-24-000065
2024-06-25 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 86 disposed 233.53 20,083.58 Form 4, filing 0001735276-24-000065
2024-06-25 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 74 disposed 231.59 17,137.66 Form 4, filing 0001735276-24-000065
2024-06-25 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 45 disposed 221.71 9,976.95 Form 4, filing 0001735276-24-000065
2024-06-25 Alnylam Pharmaceuticals, Inc.
ALNY
S, Open-market sale 26 disposed 226.82 5,897.32 Form 4, filing 0001735276-24-000065

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 0
  • Open-market sale 152
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Fitzgerald Kevin Joseph, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001886431

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.